<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">human</item><item key="factors"><item><item key="GSM8944"><item key="DISEASE STATE">multiple myeloma</item><item key="AGE">56</item><item key="MM STAGE">IIIa</item><item key="SEX">female</item></item></item><item><item key="GSM894410"><item key="DISEASE STATE">multiple myeloma</item><item key="AGE">65</item><item key="MM STAGE">IIIa</item><item key="SEX">male</item></item></item><item><item key="GSM894409"><item key="DISEASE STATE">multiple myeloma</item><item key="AGE">47</item><item key="MM STAGE">IIIa</item><item key="SEX">female</item></item></item><item><item key="GSM894408"><item key="DISEASE STATE">multiple myeloma</item><item key="AGE">52</item><item key="MM STAGE">IIIb</item><item key="SEX">female</item></item></item><item><item key="GSM894407"><item key="DISEASE STATE">healthy</item><item key="AGE">58</item><item key="MM STAGE">not specified</item><item key="SEX">male</item></item></item><item><item key="GSM894406"><item key="DISEASE STATE">healthy</item><item key="AGE">45</item><item key="MM STAGE">not specified</item><item key="SEX">female</item></item></item><item><item key="GSM894405"><item key="DISEASE STATE">healthy</item><item key="AGE">50</item><item key="MM STAGE">not specified</item><item key="SEX">female</item></item></item></item><item key="id">2500</item><item key="pop_total">0</item><item key="platform">4</item><item key="summary_wrapped">It is now well established that bone marrow (BM) constitutes a microenvironment required for differentiation. Bone marrow mesenchymal...</item><item key="geo_gse_id">E-GEOD-36474</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">4</item><item key="sample_count">7</item><item key="tags"><item>bone</item><item>bone marrow</item><item>cell</item><item>fibronectin</item><item>genome</item><item>interleukin</item><item>interleukin-6</item><item>multiple myeloma</item><item>myeloma</item><item>syndecan</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">comparison-of-bone-marrow-mesenchymal-stromal-cell</item><item key="geo_id_plat">E-GEOD-36474_A-AFFY-44</item><item key="name">Comparison of bone-marrow mesenchymal stromal cells from multiple myeloma patients and healthy donors</item><item key="created">Jul.12, 2014</item><item key="summary">It is now well established that bone marrow (BM) constitutes a microenvironment required for differentiation. Bone marrow mesenchymal stromal cells (BM-MSCs) strongly support MM cell growth, by producing a high level of Interleukin-6 (IL-6), a major MM cell growth factor. BM-MSCs also support osteoclastogenesis and angiogenesis. Previous studies have suggested that the direct (VLA-4, VCAM-1, CD44, VLA-5, LFA-1, syndecan-1,&#8230;) and indirect interactions (soluble factors) between MM plasma cells and BM-MSCs result in constitutive abnormalities in BM-MSCs. In particular, MM BM-MSCs express less CD106 and fibronectin and more DKK1, IL-1&#946; and TNF-&#945; as compared with normal BM-MSCs.  In order to gain a global view of the differences between BM-MSCs from MM patients and healthy donors, we used gene expression profiling to identify genes associated to the transformation of MM BM-MSCs. BM-MSCs were isolated from 3 healthy donors and 4 untreated multiple myeloma patients.  Total RNA from BM-MSCs was exctracted and hybridyzed on Affymetrix GeneChip&#174; Human Genome U133 Plus 2.0 Array. Amplification, hybridization and scanning were done according to standard Affymetrix protocols (www.affymetrix.com). CEL files were normalized with RMA method.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-36474</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-36474/samples/</item></data></biogps>
